title: [The Acapulco Declaration: a proposal to reduce incidence of diabetes in México].
abstract: Type 2 diabetes is the main health problem in Mexico. The growing number of cases, the high percentage of individuals with chronic complications and the treatment's cost are among the explanations for the inability in the control of this disease. Diabetes prevention is most likely to reduce the rate of growth of this diabetes burden on our health system. At- risk individuals can be identified and several interventions have proved to be effective in decreasing diabetes incidence. Diabetes prevention related interventions can become a reality with the active participation of the government and society. Thus, a joint collaboration between the medical community, the government and society is needed to phase out the diabetes epidemic. Published diabetes prevention programs were reviewed and interventions feasible for Mexico were summarized in a document called "Declaración de Acapulco". This paper was reviewed and approved by the Sociedad Mexicana de Nutrición y Endocrinología; additional endorsement was obtained from several Mexican and international societies and institutions. The manuscript describes several initiatives, which can be applied in schools, work places, primary health services and by the government. Some of these are focused on the general population; others are applicable to at-risk individuals. The "Declaración de Acapulco" is a-call-for-action position directed towards the whole society and designed to achieve effective diabetes prevention.
authors.affiliation: Departamento de Endocrinología y Metabolismo del Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, DF México. caguilarsalinas@yahoo.com
authors.forename: Carlos Alberto
authors.initials: CA
authors.lastname: Aguilar-Salinas
authors.forename: Francisco Javier
authors.initials: FJ
authors.lastname: Gómez-Pérez
mesh_terms: D000328:Adult; D002423:Cause of Death; D002648:Child; D002669:Child Welfare; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D004032:Diet; D018450:Disease Progression; D005247:Feeding Behavior; D005260:Female; D006078:Government Programs / Q000458:organization & administration; D006266:Health Education / Q000379:methods / Q000458:organization & administration; D006293:Health Promotion / Q000379:methods / Q000458:organization & administration; D006801:Humans; D015994:Incidence; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000628:therapy; D008800:Mexico / Q000453:epidemiology; D016272:Occupational Health; D010342:Patient Acceptance of Health Care; D011236:Prediabetic State / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D012306:Risk; D012955:Societies, Medical